Cargando…

Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease

Background. Lee Silverman Voice Treatment® LOUD (LSVT®) is an intensive program devised in the United States to train patients with Parkinson's disease (PD) to speak louder, at normal intensity, while keeping a good voice quality. Four weeks of LSVT® has been shown to increase vocal loudness an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Keigo, Yamamoto, Toshiyuki, Oda, Chihiro, Sato, Masako, Murakami, Takeshi, Horiguchi, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204176/
https://www.ncbi.nlm.nih.gov/pubmed/32411475
http://dx.doi.org/10.1155/2020/6585264
_version_ 1783530010807631872
author Nakayama, Keigo
Yamamoto, Toshiyuki
Oda, Chihiro
Sato, Masako
Murakami, Takeshi
Horiguchi, Satoshi
author_facet Nakayama, Keigo
Yamamoto, Toshiyuki
Oda, Chihiro
Sato, Masako
Murakami, Takeshi
Horiguchi, Satoshi
author_sort Nakayama, Keigo
collection PubMed
description Background. Lee Silverman Voice Treatment® LOUD (LSVT®) is an intensive program devised in the United States to train patients with Parkinson's disease (PD) to speak louder, at normal intensity, while keeping a good voice quality. Four weeks of LSVT® has been shown to increase vocal loudness and improve intelligibility among Japanese-speaking PD patients. However, the long-term effects of LSVT® have not been examined in these patients. Objective. This study aimed to investigate the long-term effects of LSVT® on Japanese-speaking PD patients. Methods. Twenty-one Japanese PD patients underwent a standardized course (four sessions over four consecutive days, for four weeks) of LSVT® at our hospital. Vocal loudness and intelligibility were assessed at the following three time-points: pretreatment (baseline), immediately after treatment, and at the end of the 12 month follow-up (12FU). Sound pressure levels (dB SPL) were measured during the following tasks: sustained phonation of /a/, reading a standardized text, and delivery of a monologue. Three experienced speech-language pathologists, who were blinded to patients' identities and assessment points, assessed speech intelligibility based on recorded audio samples of each participant during the reading and monologue tasks. Results. Fourteen patients were evaluated at 12FU. Changes in dB SPL from baseline to immediately after treatment were +6.5 dB, +4.2 dB, and +2.8 dB, and those from baseline until 12FU were +4.7 dB, +3.5 dB, and +2.5 dB in sustained phonation of /a/, reading a passage, and delivery of a monologue, respectively. These changes were significant (p < 0.025) in both the baseline-to-immediately-after-treatment and baseline-to-12FU intervals. Intelligibility relative to baseline was significantly improved immediately after treatment, but not at 12FU. Conclusions. LSVT® had a long-term effect on the vocal loudness of Japanese-speaking PD patients. A short-term effect was seen in intelligibility, however, there was no significant long-term effect.
format Online
Article
Text
id pubmed-7204176
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72041762020-05-14 Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease Nakayama, Keigo Yamamoto, Toshiyuki Oda, Chihiro Sato, Masako Murakami, Takeshi Horiguchi, Satoshi Rehabil Res Pract Research Article Background. Lee Silverman Voice Treatment® LOUD (LSVT®) is an intensive program devised in the United States to train patients with Parkinson's disease (PD) to speak louder, at normal intensity, while keeping a good voice quality. Four weeks of LSVT® has been shown to increase vocal loudness and improve intelligibility among Japanese-speaking PD patients. However, the long-term effects of LSVT® have not been examined in these patients. Objective. This study aimed to investigate the long-term effects of LSVT® on Japanese-speaking PD patients. Methods. Twenty-one Japanese PD patients underwent a standardized course (four sessions over four consecutive days, for four weeks) of LSVT® at our hospital. Vocal loudness and intelligibility were assessed at the following three time-points: pretreatment (baseline), immediately after treatment, and at the end of the 12 month follow-up (12FU). Sound pressure levels (dB SPL) were measured during the following tasks: sustained phonation of /a/, reading a standardized text, and delivery of a monologue. Three experienced speech-language pathologists, who were blinded to patients' identities and assessment points, assessed speech intelligibility based on recorded audio samples of each participant during the reading and monologue tasks. Results. Fourteen patients were evaluated at 12FU. Changes in dB SPL from baseline to immediately after treatment were +6.5 dB, +4.2 dB, and +2.8 dB, and those from baseline until 12FU were +4.7 dB, +3.5 dB, and +2.5 dB in sustained phonation of /a/, reading a passage, and delivery of a monologue, respectively. These changes were significant (p < 0.025) in both the baseline-to-immediately-after-treatment and baseline-to-12FU intervals. Intelligibility relative to baseline was significantly improved immediately after treatment, but not at 12FU. Conclusions. LSVT® had a long-term effect on the vocal loudness of Japanese-speaking PD patients. A short-term effect was seen in intelligibility, however, there was no significant long-term effect. Hindawi 2020-01-24 /pmc/articles/PMC7204176/ /pubmed/32411475 http://dx.doi.org/10.1155/2020/6585264 Text en Copyright © 2020 Keigo Nakayama et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nakayama, Keigo
Yamamoto, Toshiyuki
Oda, Chihiro
Sato, Masako
Murakami, Takeshi
Horiguchi, Satoshi
Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease
title Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease
title_full Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease
title_fullStr Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease
title_full_unstemmed Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease
title_short Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease
title_sort effectiveness of lee silverman voice treatment® loud on japanese-speaking patients with parkinson's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204176/
https://www.ncbi.nlm.nih.gov/pubmed/32411475
http://dx.doi.org/10.1155/2020/6585264
work_keys_str_mv AT nakayamakeigo effectivenessofleesilvermanvoicetreatmentloudonjapanesespeakingpatientswithparkinsonsdisease
AT yamamototoshiyuki effectivenessofleesilvermanvoicetreatmentloudonjapanesespeakingpatientswithparkinsonsdisease
AT odachihiro effectivenessofleesilvermanvoicetreatmentloudonjapanesespeakingpatientswithparkinsonsdisease
AT satomasako effectivenessofleesilvermanvoicetreatmentloudonjapanesespeakingpatientswithparkinsonsdisease
AT murakamitakeshi effectivenessofleesilvermanvoicetreatmentloudonjapanesespeakingpatientswithparkinsonsdisease
AT horiguchisatoshi effectivenessofleesilvermanvoicetreatmentloudonjapanesespeakingpatientswithparkinsonsdisease